Cargando…

One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction

BACKGROUND: Although beta‐blockers are recommended following myocardial infarction (MI), the benefits of long‐term treatment have not been established. The study's aim was to evaluate beta‐blocker efficacy by dose in 1‐year post‐MI survivors. METHODS AND RESULTS: The OBTAIN (Outcomes of Beta‐Bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldberger, Jeffrey J., Subačius, Haris, Marroquin, Oscar C., Beau, Scott L., Simonson, Jay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483468/ https://www.ncbi.nlm.nih.gov/pubmed/34227397 http://dx.doi.org/10.1161/JAHA.120.019017

Ejemplares similares

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed Medication
por: Pedersen, Susanne Bendesgaard, et al.
Publicado: (2016)

β‐Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way
por: Abbott, J. Dawn, et al.
Publicado: (2023)

Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021)

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
por: Joo, Seung-Jae
Publicado: (2023)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review
por: Lanham, David, et al.
Publicado: (2019)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
por: Amino, Mari, et al.
Publicado: (2021)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
por: Hu, Mengjin, et al.
Publicado: (2022)

Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction
por: Zhong, Yue, et al.
Publicado: (2017)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

Clinical Impact of Beta Blockers in Patients with Myocardial Infarction from the Korean National Health Insurance Database
por: Won, Hoyoun, et al.
Publicado: (2020)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

Exercise based assessment of cardiac autonomic function in type 1 versus type 2 diabetes mellitus
por: Goldberger, Jeffrey J., et al.
Publicado: (2022)

The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
por: Park, Kyungil, et al.
Publicado: (2018)

Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
por: Kezerashvili, Anna, et al.
Publicado: (2012)

Self‐Controlled Case‐Series Study to Verify the Effect of Adherence to Beta‐Blockers in Secondary Prevention of Myocardial Infarction
por: Di Bartolomeo, Stefano, et al.
Publicado: (2015)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging
por: Hoffmeister, C., et al.
Publicado: (2014)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022)

Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction
por: Hioki, Hirofumi, et al.
Publicado: (2015)

High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity
por: Woodward, Christina, et al.
Publicado: (2014)

Influence of Beta Blockers on Survival in Dogs with Severe Subaortic Stenosis
por: Eason, B.D., et al.
Publicado: (2014)

Effects of Beta-Blockers on Melanoma Microenvironment and Disease Survival in Human
por: Wrobel, Ludovic Jean, et al.
Publicado: (2020)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Due caution using early β-blockers for acute myocardial infarction
por: McKee, Scott, et al.
Publicado: (2007)

Randomized Evaluation of Beta Blocker and ACE-Inhibitor/Angiotensin Receptor Blocker Treatment for Post Infarct Angina in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries: A MINOCA-BAT Sub Study Rationale and Design
por: Pasupathy, Sivabaskari, et al.
Publicado: (2021)

Class effect of beta-blockers in survivors of ST-elevation myocardial infarction: A nationwide cohort study using an insurance claims database
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction
por: Huang, Wei-Ping, et al.
Publicado: (2018)

Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
por: Liu, Sheng-Fu, et al.
Publicado: (2021)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease
por: Zvizdic, Faris, et al.
Publicado: (2019)

Beta-blocker and survival in patients with lung cancer: A meta-analysis
por: Lei, Zhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a6uevdb4hh8kaj66vk3fihah9u